Migraine Inheritance Facts and Headache-Related Genes

MTHFR Gene and TRPV1 Gene that Contribute to Migraines

Tamara Staples/Getty Images

 If you suffer from incapacitating migraines, there is a good chance that your sister, cousin, or mother does as well. This is because your genes make you more or less susceptible to developing migraines.

Let's explore the genetics of migraines and what this means for you and your family.

The Interaction Between Genes and Environment in Headaches

The majority of headaches are the result of multiple genetic and environmental factors interacting in a complicated web. While many of you work incessantly on controlling environmental factors through trigger avoidance and behavior modification, you obviously cannot change the genes you were born with. However, by studying the genetics involved in migraine origination, scientists can create new drugs that target specific genes, in the hopes of curing, if not alleviating our burdensome and debilitating headaches.

What Types of Genes are Involved in Migraines?

There is a significant role of inheritance in the development of migraines and other primary headaches. This has been shown through multiple family and twin studies. But what are the actual genes being passed down?  Below is an example of two genes thought to play a role in the formation of migraines.

One gene is called the MTHFR gene, which stands for the long term, methylenetetrahydrofolate reductase. This gene is involved in the homocysteine pathway. Homocysteine is an amino acid in our bloodstream that when elevated, may lead to blood vessel inflammation, as well as firing of certain nerve cells that may be involved in headaches. Certain mutations in this gene have been associated with both migraines and cluster headaches.

One study in Pharmacogenetics and Genomics found that in women with migraine with aura, vitamin supplementation significantly lowered their homocysteine levels, migraine severity, and migraine disability levels, compared to women who took placebo. Vitamin supplementation was done with vitamin B6, B9 (folic acid), and B12, which have been found to lower homocysteine levels in the bloodstream.

In addition, when the vitamin-treated group was examined closely, it was found that patients with a certain allele of the MTHFR gene had a significantly greater reduction in homocysteine levels, as well as migraine severity and disability scores, than those with a different allele. An allele is an alternative form of a gene that occupies a specific spot on a specific chromosome. This finding indicates that certain gene variants may influence how well migraineurs respond to vitamin supplementation.

TRPV1 (Transient Related Potential Vanilloid Type 1)has been proposed to play a vital role in migraine sensitization — a term that refers to an overly sensitive or reactive nervous system in patients with migraines.

This gene has plays a role in migraine hyperalgesia and allodynia, two conditions that can occur during a migraine attack. Hyperalgesia refers to an increased response to a painful stimulus. Allodynia refers to a painful response to a normally harmless stimulus, such as feeling discomfort with a simple touch during a migraine attack.

Over the past few years, drugs targeting the TRP channels have been studied as potential migraine therapies. One example of a drug that targets the TRPV1 channel is sumatriptan, a common migraine therapy.

What Does This Mean for Me?

The big picture here is that migraines have a strong genetic basis. By learning more about the specific genes that predispose one to migraines, scientists can then target drugs to these genes.

Was this page helpful?
Article Sources
  • Also, understanding the genetic basis of migraine may relieve some of the burden individuals experience, as they try to control their migraine attacks. Consider discussing your family history with your healthcare provider, as this may provide some insight into your migraines and influence future therapy.


    Evans MS, Cheng X, Jeffry JA, Disney KE, Premkumar LS. Sumatriptan inhibits TRPV1 channels in trigeminal neurons. Headache. 2012 May;52(5):773-84.

    Meents JE, Neeb L, Reuter U. TRPV1 in migraine pathophysiology. Trends Mol Med. 2010;14(4):153–159.

    Menon S, Lea RA, Roy B, Hanna M, Wee S, Haupt LM, Oliver C, Griffiths LR. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation. Pharmacogenet Genomics. 2012 Oct;22(10):741-9.

    Rainero, I. Rubino E, Paemeleire K, Gai A, Vacca A et al. Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain. 2013; Jul 12;14(1):61. 14(1): 61.

    Russell MB. Genetics in primary headaches. J Headache Pain. 2007 Jun;8(3):190-5.